Pathway Genomics Company

Pathway Genomics provides a comprehensive set of genomic testing services across the healthcare spectrum, including tests for general health and wellness, liquid biopsy, pharmacogenomics, hereditary cancer risk and carrier screening. Its general health and wellness tests, including PathwayFit®, Cardiac DNA Insight®, and SkinFit™, equip physicians and patients with genetic information to support lifestyle choices. Liquid biopsy tests, including CancerIntercept™ Detect and Monitor, are non-invasive tests for detection of circulating tumor DNA. Pathway’s pharmacogenomics tests (Mental Health DNA Insight® and Pain Medication DNA Insight®) provide genetic information to help guide selection of optimal medication for management of mental health and pain disorders. Pathway’s hereditary cancer risk tests, including BRCATrue® and ColoTrue®, evaluate genetic factors for future cancer risk. Pathway Genomics Corporation operates a clinical laboratory to provide its commercial genetic testing services to physicians and their patients in the United States and internationally. Pathway Genomics Corporation was incorporated in 2008 and is based in San Diego, California.

Investors

Funding Status: Late Stage Venture
Industry: Biotechnology, Genetics, Health Care, Medical
Estimated Revenue: $1M to $10M
Technology: NeuroTech
Headquarters: San Diego, California, United States
Total Funding: $43M
Last Funding Type: Series E
Investor Type: For Profit
Employee Number: 101-250
Investors Number: 2
Founded Date: 2008-09-01
Register and Claim Ownership